Found 26 matching trials
Korea Comirnaty Post-marketing Surveillance N/A This study will collect information on the safety of BNT162b2 products for ...
Show More Status
Active Not Recruiting
Learn More & Join Trial
Immunogenicity of COVID-19 Vaccine Co-administration With Influenza Vaccine in Healthy Volunteers EARLY_PHASE1 This study, a pilot randomized controlled trial, single-blind (outcome asse...
Show More Location
Faculty of Medicine, Prince of Songkla University
Learn More & Join Trial
COVID-19 Fourth Dose Study in Australia PHASE3 This clinical trial will be a blinded, randomised study to determine the sa...
Show More Location
Royal Children's Hospital, Murdoch Children's Research Institute
Learn More & Join Trial
Immunogenicity and Safety of AdCLD-CoV19-1 OMI As a Booster: a COVID-19 Preventive Vaccine in Healthy Volunteers PHASE3 The immunogenicity and safety of AdCLD-CoV19-1 OMI (5.0x10\^10 VP (0.5 mL)/...
Show More Status
Active Not Recruiting
Location
The Medical City-Iloilo
Learn More & Join Trial
COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders PHASE2 This is a randomized, multi-site, adaptive, open-label clinical trial compa...
Show More Location
UCLA Medical Center: Division of Rheumatology
Learn More & Join Trial
Secondary Databased Post-marketing Surveillance Study of BNT162b2 N/A This study is to assess the post-marketing safety of BNT162b2 products usin...
Show More Learn More & Join Trial
A Study of the Immunogenicity and Safety of SCTV01C in Population Aged ≥12 Years and Previously Vaccinated With Inactivated COVID-19 Vaccine PHASE2 The objective of this study is to evaluate the immunogenicity and safety of...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Learn About Bivalent COVID-19 RNA Vaccine Candidate(s) in Healthy Infants and Children PHASE1 The purpose of this clinical trial is to learn about the safety and immune ...
Show More Location
Multiple Locations
Learn More & Join Trial
Immunogenicity and Reactogenicity of the Beta-variant Recombinant Protein Booster Vaccine (VidPrevtyn Beta, Sanofi) Compared to a Bivalent mRNA Vaccine (Comirnaty Original/Omicron BA.4-5, BioNTech-Pfizer) in Adults Previously Vaccinated With at Least 3 Doses of COVID-19 mRNA Vaccine PHASE3 The objective of this trial is to compare the immunogenicity and the safety...
Show More Location
CIC 1417 Cochin-Pasteur
Learn More & Join Trial
Immunocompromised Swiss Cohorts Based Trial Platform PHASE3 This study is to set up a flexible trial platform using two existing nation...
Show More Location
University Hospital Basel
Learn More & Join Trial